Clinical Trial

45th Multicenter Airway Research Collaboration

Study acronym: MARC-45
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The study is a randomized controlled trial on the effect of emergency department initiation of Airsupra on acute asthma "recurrence" at 3 months and other related outcomes (acute asthma relapse, asthma control).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-09; most recent amendment 2026-04-14.
Status change: Not Yet Recruiting → Recruiting 2026-04-14
Trial Details
NCT Number NCT07166939
Lead Sponsor Massachusetts General Hospital
Conditions Asthma Acute, Asthma Exacerbation, Asthma, Asthma Control Level
Enrollment 1,860 participants
Start Date 2025-11-07
Primary Completion 2027-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-04-17